Nörobehçet ve Ayırıcı Tanısı

Behc ̧et H (1937) Uber residivierende, aphtose durch ein Virus verursachtes Geschwure am Mund, am Auge und an der Genit- alien. Derm Wschr 105:1152–1157

Saip, S., Akman-Demir, G., & Siva, A. (2014). Neuro-Behçet syndrome. Handbook of clinical neurology, 121, 1703-1723.

Richard E. Behrman, Robert M. Kliegman, Hal B. Jenson. Nelson Textbook of Pediatrics. Philadelphia :W.B. Saunders Co., 2024,p1514

Gül, A. (2015, July). Pathogenesis of Behçet’s disease: autoinflammatory features and beyond. In Seminars in immunopathology (Vol. 37, No. 4, pp. 413-418). Berlin/Heidelberg: Springer Berlin Heidelberg.

Kürtüncü, M., Tüzün, E., & Akman-Demir, G. (2016). Behçet’s disease and nervous system involvement. Current treatment options in neurology, 18, 1-12.

Yazici, Y., Yurdakul, S., & Yazici, H. (2010). Behçet's syndrome. Current rheumatology reports, 12(6), 429–435.

Ozen S. (2010). Pediatric onset Behçet disease. Current opinion in rheumatology, 22(5), 585–589.

Borhani-Haghighi, A., Kardeh, B., Banerjee, S., Yadollahikhales, G., Safari, A., Sahraian, M. A., & Shapiro, L. (2020). Neuro-Behcet's disease: an update on diagnosis, differential diagnoses, and treatment. Multiple sclerosis and related disorders, 39, 101906.

Coit, P., Mumcu, G., Ture-Ozdemir, F., Unal, A. U., Alpar, U., Bostanci, N., ... & Sawalha, A. H. (2016). Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behcet's disease. Clinical Immunology, 169, 28-35.

Hatemi, G., & Yazici, H. (2011). Behçet’s syndrome and micro-organisms. Best practice & research Clinical rheumatology, 25(3), 389-406.

Cicek, D., Dağlı, A. F., Aydin, S., Baskaya Dogan, F., Dertlioğlu, S. B., Uçak, H., & Demir, B. (2014). Does hepcidin play a role in the pathogenesis of aphthae in Behçet's disease and recurrent aphthous stomatitis?. Journal of the European Academy of Dermatology and Venereology, 28(11), 1500-1506.

Emmi, G., Silvestri, E., Squatrito, D., D’Elios, M. M., Ciucciarelli, L., Prisco, D., & Emmi, L. (2014). Behçet’s syndrome pathophysiology and potential therapeutic targets. Internal and emergency medicine, 9, 257-265.

Na, S. Y., Park, M. J., Park, S., & Lee, E. S. (2013). Up-regulation of Th17 and related cytokines in Behçet’s disease corresponding to disease activity. Clin Exp Rheumatol, 31(3 Suppl 77), 32-40.

Zierhut, M., Mizuki, N., Ohno, S., Inoko, H., Gül, A., Onoé, K., & Isogai, E. (2003). Immunology and functional genomics of Behçet's disease. Cellular and molecular life sciences : CMLS, 60(9), 1903–1922.

Sakly, K., Lahmar, R., Nefzi, F., Hammami, S., Harzallah, O., Sakly, N., Sakly, W., Hassine, M., Mahjoub, S., Ghedira, I., & Feki, S. (2014). Phenotypic abnormalities of peripheral blood mononuclear cells in patients with Behçet's disease and association with HLA-B51 expression. Immunological investigations, 43(5), 463–478.

Saruhan-Direskeneli, G., Yentür, S. P., Akman-Demir, G., Işık, N., & Serdaroğlu, P. (2003). Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases. Journal of neuroimmunology, 145(1-2), 127-134.

Akman-Demir, G., Tüzün, E., İçöz, S., Yeşilot, N., Yentür, S. P., Kürtüncü, M., ... & Saruhan-Direskeneli, G. (2008). Interleukin-6 in neuro-Behçet’s disease: association with disease subsets and long-term outcome. Cytokine, 44(3), 373-376.

Marta, M., Santos, E., Coutinho, E., Silva, A. M., Correia, J., Vasconcelos, C., & Giovannoni, G. (2015). The role of infections in Behçet disease and neuro-Behçet syndrome. Autoimmunity Reviews, 14(7), 609-615.

de Menthon, M., Lavalley, M. P., Maldini, C., Guillevin, L., & Mahr, A. (2009). HLA–B51/B5 and the risk of Behçet's disease: A systematic review and meta‐analysis of case–control genetic association studies. Arthritis Care & Research, 61(10), 1287-1296.

Piga, M., & Mathieu, A. (2011). Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region. Rheumatology, 50(2), 299-310.

Zhang, M., Xu, W. D., Wen, P. F., Liang, Y., Liu, J., Pan, H. F., & Ye, D. Q. (2013). Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet’s disease: an updated meta-analysis. Molecular Vision, 19, 1913.

Hirohata, S. (2008). Histopathology of central nervous system lesions in Behçet's disease. Journal of the neurological sciences, 267(1-2), 41-47.

Taskapilioglu, O., Seferoglu, M., Akkaya, C., Hakyemez, B., Yusufoglu, C., Basak, A. N., ... & Bora, I. (2009). Delayed diagnosis of a neuroBehçet patient with only brainstem and cerebellar atrophy: literature review. Journal of the neurological sciences, 277(1-2), 160-163.

Kikuchi, H., Takayama, M., & Hirohata, S. (2014). Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Behçet's disease. Journal of the neurological sciences, 337(1-2), 80-85.

Xu ZhanWen, X. Z., Zhao XingZhou, Z. X., & Li YaQin, L. Y. (2014). Aneurysms of the sinus of Valsalva in a patient with Behcet's disease.

Lopalco, G., Lucherini, O. M., Lopalco, A., Venerito, V., Fabiani, C., Frediani, B., ... & Iannone, F. (2017). Cytokine signatures in mucocutaneous and ocular behcet’s disease. Frontiers in Immunology, 8, 200.

Hamzaoui, K., Borhani-Haghighi, A., Kaabachi, W., & Hamzaoui, A. (2014). Increased interleukin 33 in patients with neuro-Behcet's disease: correlation with MCP-1 and IP-10 chemokines. Cellular & molecular immunology, 11(6), 613-616.

Al-Araji, A., & Kidd, D. P. (2009). Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. The Lancet Neurology, 8(2), 192-204.

Kalra, S., Silman, A., Akman-Demir, G., Bohlega, S., Borhani-Haghighi, A., Constantinescu, C. S., ... & Al-Araji, A. (2014). Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations. Journal of neurology, 261, 1662-1676.

Caruso, P., & Moretti, R. (2018). Focus on neuro-Behçet's disease: a review. Neurology India, 66(6), 1619-1628.

Bulur, I., & Onder, M. (2017). Behçet disease: new aspects. Clinics in dermatology, 35(5), 421-434.